Mark Beveridge

Mark Beveridge appears in our data through filings on Moberg Pharma AB shares, published by Finansinspektionen. In total, 7 filings cover trades dated from 22 November 2019 to 11 November 2021.

Both buying and selling appear: 4 purchases worth €31k, against 2 sales worth €15k. Netting one side against the other leaves €17k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2021, the count stands at 3 purchases and no sales.

Half of the purchases are above €2,385 and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 11 November 2021, the filings show an open-market purchase worth €2,997 in Moberg Pharma AB. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.